Case number 1:22-cv-00640
Horizon Medicines LLC et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 28, 2023 | 91 | SO ORDERED D.I. 90 Stipulation of Dismissal filed by Apotex Inc., Apotex Corp., ***Civil Case Terminated.. Signed by Judge Christopher J. Burke on 4/28/2023. (dlb) (Entered: 04/28/2023) (2) |
| Apr 28, 2023 | 90 | STIPULATION of Dismissal of Action with Prejudice by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 04/28/2023) (2) |
| Apr 19, 2023 | 89 | ORAL ORDER: The Court, having reviewed the parties' April 14, 2023 joint status letter, (D.I. 88), hereby ORDERS that by no later than April 28, 2023, the parties shall submit a further joint status update. Ordered by Judge Christopher J. Burke on 4/19/2023. (dlb) (Entered: 04/19/2023) (0) |
| Apr 14, 2023 | 88 | Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding Joint Status Report. (Dorsney, Kenneth) (Entered: 04/14/2023) (1) |
| Mar 31, 2023 | 87 | STIPULATION to Stay All Case Deadlines by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 03/31/2023) (2) |
| Mar 15, 2023 | 86 | Joint STIPULATION to extend briefing schedule by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 03/15/2023) (2) |
| Mar 2, 2023 | 85 | Joint STIPULATION to extend briefing schedule by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/02/2023) (2) |
| Feb 10, 2023 | 84 | NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production (Nos. 3-10) filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC.(Russell, Andrew) (Entered: 02/10/2023) (2) |
| Jan 19, 2023 | 83 | STIPULATION regarding Dismissal of Apotex's Counterclaims by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 01/19/2023) (2) |
| Jan 6, 2023 | 82 | Joint STIPULATION and [Proposed Order] regarding Briefing Schedules and memorializing the Joint Status Report re 78 Oral Order, by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 01/06/2023) (4) |
| Dec 30, 2022 | 81 | STIPULATION TO EXTEND TIME for the parties to file joint stipulation memorializing the joint status report to January 6, 2023 - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 12/30/2022) (2) |
| Dec 21, 2022 | 80 | Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney and Nathan R. Hoeschen regarding Joint Status Update. (Dorsney, Kenneth) (Entered: 12/21/2022) (2) |
| Dec 20, 2022 | 79 | STIPULATION TO EXTEND TIME for the Parties to Submit Joint Status Report to December 21, 2022 - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 12/20/2022) (2) |
| Dec 6, 2022 | 78 | ORAL ORDER: The Court, having reviewed the parties' December 5, 2022 joint status letter, (D.I. 77), hereby ORDERS that by no later than December 20, 2022, the parties shall submit a further joint status update. Ordered by Judge Christopher J. Burke on 12/6/2022. (dlb) (Entered: 12/06/2022) (0) |
| Dec 5, 2022 | 77 | Letter to The Honorable Christopher J. Burke from Karen E. Keller and Kenneth L. Dorsney regarding Joint Status update - re 76 Oral Order,. (Keller, Karen) (Entered: 12/05/2022) (2) |
| Nov 14, 2022 | 76 | ORAL ORDER: The Court, having reviewed the parties' November 14, 2022 joint status letter, (D.I. 75), hereby ORDERS that by no later than December 5, 2022, the parties shall submit a further joint status update. Ordered by Judge Christopher J. Burke on 11/14/2022. (mlc) (Entered: 11/14/2022) (0) |
| Nov 14, 2022 | 75 | Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen and Kenneth L. Dorsney regarding Joint Status Report - re 74 Oral Order. (Hoeschen, Nathan) (Entered: 11/14/2022) (2) |
| Nov 8, 2022 | 74 | ORAL ORDER: The Court hereby ORDERS that by no later than November 14, 2022, the parties shall submit a joint status letter. Ordered by Judge Christopher J. Burke on 11/08/2022. (srs) (Entered: 11/08/2022) (0) |
| Nov 7, 2022 | 73 | ORDER regarding D.I. 72 Memorandum Opinion and GRANTING Defendants' Motion for Summary Judgment. Signed by Judge Christopher J. Burke on 11/7/22. (mlc) (Entered: 11/07/2022) (1) |
| Nov 7, 2022 | 72 | MEMORANDUM OPINION regarding Defendants' Motion for Summary Judgment. Signed by Judge Christopher J. Burke on 11/7/22. (mlc) (Entered: 11/07/2022) (27) |
| Sep 29, 2022 | 71 | NOTICE of Withdrawal of Douglas W. Cheek by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC (Hoeschen, Nathan) (Entered: 09/29/2022) (2) |
| Sep 6, 2022 | 70 | REDACTED VERSION of 68 Letter by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 09/06/2022) (8) |
| Aug 30, 2022 | 69 | Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding Summary Judgment Hearing. (Dorsney, Kenneth) (Entered: 08/30/2022) (30) |
| Aug 30, 2022 | 68 | [SEALED] Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen regarding response to the Court's August 23, 2022 questions - re Motion Hearing,,. (Attachments: # 1 Exhibit 1)(Hoeschen, Nathan) (Entered: 08/30/2022) (0) |
| Aug 30, 2022 | 67 | Official Transcript of Motion held on 08.23.2022 before Judge Christopher Burke. Court Reporter/Transcriber Michele Rolfe,Email: michele_rolfe@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/20/2022. Redacted Transcript Deadline set for 9/30/2022. Release of Transcript Restriction set for 11/28/2022. (Rolfe, Michele) (Entered: 08/30/2022) (142) |
| Aug 5, 2022 | 66 | REDACTED VERSION of 64 Reply Brief by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 08/05/2022) (14) |
| Jul 29, 2022 | 65 | DECLARATION re 64 Reply Brief MOTION for Summary Judgment (Declaration of J. Janusz) by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 07/29/2022) (30) |
| Jul 29, 2022 | 64 | [SEALED] REPLY BRIEF re 31 MOTION for Summary Judgment and proposed order filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 07/29/2022) (0) |
| Jul 26, 2022 | 63 | ANSWER to 28 Answer to Complaint, Counterclaim [Plaintiffs' Answer and Affirmative Defenses to Defendants' Counterclaims] by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC.(Keller, Karen) (Entered: 07/26/2022) (9) |
| Jul 25, 2022 | 62 | REDACTED VERSION of 56 Letter by HZNP Finance LTD.. (Keller, Karen) (Entered: 07/25/2022) (4) |
| Jul 25, 2022 | 61 | REDACTED VERSION of 53 Declaration, by HZNP Finance LTD.. (Keller, Karen) (Entered: 07/25/2022) (30) |
| Jul 25, 2022 | 60 | REDACTED VERSION of 52 Answering Brief in Opposition, by HZNP Finance LTD.. (Keller, Karen) (Entered: 07/25/2022) (27) |
| Jul 25, 2022 | 59 | REDACTED VERSION of 55 Letter by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 07/25/2022) (5) |
| Jul 25, 2022 | 58 | ORAL ORDER: The Court, having reviewed the discovery dispute motion ("Motion"), (D.I. 47), and the parties' letter briefs, (D.I. 48; D.I. 50; D.I. 55; D.I. 56), hereby ORDERS as follows: (1) With regard to Interrogatory No. 1 ("Rogg 1"), Plaintiffs' request is DENIED. Rogg 1 appears to be in contrast with the procedural posture of this case, wherein the parties agreed to focus on Defendants' summary judgment motion and put off a case schedule -- including discovery on other aspects of the case. (D.I. 48 at 1) Plaintiffs never previously hinted -- either to the District Court or to Defendants -- that discovery like this would be pursued prior to resolution of the summary judgment motion. Moreover, Defendants have confirmed in their response to Rogg 1 that they made distributions of the product at issue on May 9, 2022, and made no other distributions thereafter. (D.I. 50, ex. D at 6); (2) With regard to Plaintiffs' Requests for Production Nos. 1-2 and Interrogatory No. 2, Plaintiffs' request is also DENIED. Although the Court would have been prepared to allow targeted discovery related to Defendants' summary judgment motion if Plaintiffs could have explained how such discovery was relevant to that motion, Plaintiffs failed to sufficiently do so in their briefing, despite having two chances to make that case. (D.I. 50; D.I. 56) While Plaintiffs claim that the requested discovery is relevant to the parties' intent as to Apotex being the first filer, (D.I. 50 at 1-2; D.I. 56 at 2), they never specifically explained how that fact relates to the particular summary judgment arguments that the parties are actually making in their currently-filed opening and responsive summary judgment briefs.; and (3) Because four briefs were filed regarding the Motion, an adequate opportunity was provided for the parties to make their presentations regarding the Motion. The Court thus resolves the Motion on the papers via this Order, and today's teleconference is hereby CANCELED. Ordered by Judge Christopher J. Burke on 7/25/2022. (mlc) (Entered: 07/25/2022) (0) |
| Jul 22, 2022 | 57 | STIPULATION TO EXTEND TIME to file proposed redacted versions of Plaintiffs' Brief in Opposition to Defendants' Motion for Summary Judgment (D.I. 52) and the Declaration of Sanya Sukduang in Support of Plaintiffs' Brief in Opposition (D.I. 53) to July 25, 2022 - filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 07/22/2022) (2) |
| Jul 19, 2022 | 56 | [SEALED] Letter to Honorable Christopher J. Burke from Nathan R. Hoeschen regarding Discovery Dispute and Opposition - re 48 Letter. (Hoeschen, Nathan) (Entered: 07/19/2022) (0) |
| Jul 19, 2022 | 55 | [SEALED] Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding Apotex's Responsive Discovery Dispute Letter - re 50 Letter, 44 Order Setting Teleconference,,,,,,,. (Dorsney, Kenneth) (Entered: 07/19/2022) (0) |
| Jul 19, 2022 | 54 | REDACTED VERSION of 50 Letter, by HZNP Medicines LLC. (Hoeschen, Nathan) (Entered: 07/19/2022) (30) |
| Jul 15, 2022 | 53 | [SEALED] DECLARATION re 52 Answering Brief in Opposition, (Declaration of Sanya Sukduang) by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Hoeschen, Nathan) (Entered: 07/15/2022) (0) |
| Jul 15, 2022 | 52 | [SEALED] ANSWERING BRIEF in Opposition re 31 MOTION for Summary Judgment and proposed order filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC.Reply Brief due date per Local Rules is 7/22/2022. (Hoeschen, Nathan) (Entered: 07/15/2022) (0) |
| Jul 13, 2022 | 51 | ORAL ORDER: The Court, having reviewed the parties' July 12, 2022 letter, (D.I. 49), hereby ORDERS that the August 23, 2022 hearing on Defendants Motion for Summary Judgment will be held in-person in Courtroom 6C. Ordered by Judge Christopher J. Burke on 7/13/2022. (dlb) (Entered: 07/13/2022) (0) |
| Jul 12, 2022 | 50 | [SEALED] Letter to The Honorable Magistrate Judge Christopher J. Burke from Nathan R. Hoeschen regarding Discovery Dispute - re 44 Order Setting Teleconference,,,,,,,. (Attachments: # 1 Text of Proposed Order, # 2 Declaration of Douglas Cheek in Support of Plaintiffs' Motion to Compel, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G)(Hoeschen, Nathan) (Entered: 07/12/2022) (0) |
| Jul 12, 2022 | 49 | Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen regarding joint agreement to conduct an in-person hearing - re 37 Order Setting Hearing on Motion,,,. (Hoeschen, Nathan) (Entered: 07/12/2022) (1) |
| Jul 12, 2022 | 48 | Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding Discovery Dispute - re 44 Order Setting Teleconference,,,,,,,. (Dorsney, Kenneth) (Entered: 07/12/2022) (30) |
| Jul 11, 2022 | 47 | MOTION re Joint Motion for a Teleconference to Resolve Discovery Dispute re 44 Order Setting Teleconference,,,,,,, - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 07/11/2022) (2) |
| Jul 6, 2022 | 46 | REDACTED VERSION of 33 Declaration of Joseph M. Janusz in support of Apotex's Motion for Summary Judgment by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 07/06/2022) (30) |
| Jul 6, 2022 | 45 | REDACTED VERSION of 32 Opening Brief in Support of Motion for Summary Judgment by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 07/06/2022) (22) |
| Jul 5, 2022 | 44 | ORAL ORDER Setting Teleconference: The Court has reviewed the parties' July 5, 2022 letter requesting a discovery dispute teleconference regarding one discovery dispute. (D.I. 43) It hereby ORDERS as follows with regard to this dispute: (1) The parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website.; (2) A discovery dispute teleconference is set for 7/25/2022 at 03:30 PM before Judge Christopher J. Burke.; (3) By July 12, 2022, any party seeking relief shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By July 19, 2022, any party opposing the application for relief may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining that party's reasons for its opposition.; (4) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (5) By no later than July 19, 2022, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the teleconference (however, if any party advises the Court in advance that a newer attorney will argue the dispute, see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf, then the Court will go forward with the conference). Ordered by Judge Christopher J. Burke on 7/5/22. (mlc) (Entered: 07/05/2022) (0) |
| Jul 5, 2022 | 43 | Letter to The Honorable Christopher J. Burke from Cortlan S. Hitch regarding request for the scheduling of a discovery teleconference. (Hitch, Cortlan) (Entered: 07/05/2022) (1) |
| Jul 1, 2022 | 42 | STIPULATION TO EXTEND TIME for Apotex to file redacted version of Opening Brief and related Declaration in support of their Motion for Summary Judgment to July 6, 2022 - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 07/01/2022) (2) |
| Jul 1, 2022 | 41 | NOTICE OF SERVICE of Apotex's response to Plaintiffs' First Set of Interrogatories (No. 1) filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) (Entered: 07/01/2022) (2) |
| Jul 1, 2022 | 40 | PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 7/1/2022. (dlb) (Entered: 07/01/2022) (20) |
| Jul 1, 2022 | 39 | PROPOSED ORDER [Proposed] Protective Order by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 07/01/2022) (20) |
| Jun 30, 2022 | 38 | STIPULATION TO EXTEND TIME for Horizon to file a response to Apotexs Counterclaims to July 26, 2022 - filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 06/30/2022) (2) |
| Jun 28, 2022 | 37 | ORAL ORDER Setting Hearing on Motion: The Court HEREBY ORDERS that oral argument on the pending motion for summary judgment, (D.I. 31), will be held on August 23, 2022 at 11:00 AM before Judge Christopher J. Burke. The hearing will be held in a Courtroom to be determined, unless there is joint agreement to conduct the hearing via videoconference using the Microsoft Teams platform. By July 12, 2022, the parties shall submit a joint letter indicating whether there is joint agreement to conduct the hearing via videoconference or whether the hearing will proceed in person. If any party participant has a COVID-19 related concern about participating in an in-person hearing, they may note that in the joint letter. Two and a half hours will be allocated for argument, to be split equally between the parties. Ordered by Judge Christopher J. Burke on 6/28/2022. (dlb) (Entered: 06/28/2022) (0) |
| Jun 28, 2022 | 36 | Letter to Honorable Christopher J. Burke from Nathan R. Hoeschen regarding the case schedule. (Hoeschen, Nathan) (Entered: 06/28/2022) (1) |
| Jun 28, 2022 | 35 | REDACTED VERSION of 28 Answer to Complaint, Counterclaim by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 06/28/2022) (30) |
| Jun 27, 2022 | 34 | NOTICE OF SERVICE of 1. Plaintiffs' First Set of Requests for Production (Nos. 1-2) 2. Plaintiffs' Second Set of Interrogatories (No. 2) filed by HZNP Medicines LLC.(Hoeschen, Nathan) (Entered: 06/27/2022) (2) |
| Jun 24, 2022 | 33 | [SEALED] DECLARATION re 32 Opening Brief in Support Declaration of JOSEPH M. JANUSZ by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 06/24/2022) (0) |
| Jun 24, 2022 | 32 | [SEALED] OPENING BRIEF in Support re 31 MOTION for Summary Judgment and proposed order filed by Apotex Corp., Apotex Inc..Answering Brief/Response due date per Local Rules is 7/8/2022. (Hitch, Cortlan) (Entered: 06/24/2022) (0) |
| Jun 24, 2022 | 31 | MOTION for Summary Judgment and proposed order - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 06/24/2022) (2) |
| Jun 23, 2022 | 30 | ORAL ORDER: By no later than June 30, 2022, the parties shall file a joint letter to the Court, of no more than two-single-spaced pages, indicating whether either side wishes the Court to issue a Scheduling Order in the case at this time (or whether the parties believe that the Court should address the forthcoming early motion for summary judgment first, before any schedule is set). Ordered by Judge Christopher J. Burke on 6/23/2022. (dlb) (Entered: 06/23/2022) (0) |
| Jun 21, 2022 | 29 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp.; Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 06/21/2022) (2) |
| Jun 21, 2022 | 28 | [SEALED] ANSWER to 1 Complaint, , COUNTERCLAIM against HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 06/21/2022) (0) |
| Jun 21, 2022 | 27 | STIPULATION to File Confidential Documents Under Seal by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 06/21/2022) (2) |
| Jun 2, 2022 | 26 | STIPULATION TO EXTEND TIME for Apotex to respond to the Complaint to June 21, 2022 - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 06/02/2022) (3) |
| May 31, 2022 | 25 | STIPULATION Stay briefing on Horizon's Motion for Preliminary Injunction by Apotex Corp.. (Hitch, Cortlan) (Entered: 05/31/2022) (2) |
| May 31, 2022 | 24 | ORDER Approving Magistrate Consent submitted by parties. Case reassigned to Magistrate Judge Christopher J. Burke. Signed by Judge Colm F. Connolly on 5/31/2022. (etg) (Entered: 05/31/2022) (1) |
| May 27, 2022 | 23 | VAC Magistrate Consent completed by the parties filed by All Defendants (Hitch, Cortlan) (Entered: 05/27/2022) (1) |
| May 27, 2022 | 22 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (No. 1) filed by Horizon Medicines LLC.(Hoeschen, Nathan) (Entered: 05/27/2022) (2) |
| May 27, 2022 | 21 | STIPULATION Summary Judgment Briefing Schedule by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 05/27/2022) (4) |
| May 24, 2022 | 20 | REDACTED VERSION of 10 MOTION to Expedite Proceedings and Certification Pursuant to Local Rule 7.1.1 by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/24/2022) (9) |
| May 24, 2022 | 19 | REDACTED VERSION of 9 Declaration by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/24/2022) (16) |
| May 24, 2022 | 18 | REDACTED VERSION of 8 Opening Brief in Support,, by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/24/2022) (30) |
| May 23, 2022 | 17 | MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Douglas W. Cheek, Jonathan Davies, Mazda Antia and Erin Trenda - filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/23/2022) (7) |
| May 20, 2022 | 16 | ORAL ORDER re 14 VAC Notice, Consent, Non-Consent, Magistrate Referral - IT IS HEREBY ORDERED that the deadline for the parties to submit the Notice of Consent of Absence of Consent to Proceed Before a United States Magistrate Judge is RESET for 6/7/2022. ORDERED by Judge Maryellen Noreika on 5/20/2022. (dlw) (Entered: 05/20/2022) (0) |
| May 20, 2022 | 15 | Joint PROPOSED ORDER on Expedited Briefing Schedule by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/20/2022) (2) |
| May 18, 2022 | 14 | VAC Notice, Consent, Non-Consent, Magistrate Referral (ntl) (Entered: 05/18/2022) (1) |
| May 18, 2022 | 13 | ORAL ORDER: This case has been assigned to the District of Delaware's Vacant Judgeship ("VAC"). Detailed information relating to VAC cases may be found in the Court's Announcement of March 3, 2022 and Standing Order No. 2022-VAC-1 (March 9, 2022), which are found on the Court's website. Consistent with the foregoing Announcement and Standing Order, IT IS HEREBY ORDERED that the parties shall file the "Notice of Consent or Absence of Consent to Proceed Before a United States Magistrate Judge," being docketed along with the instant order, no later than sixty (60) days after service of the Complaint on the first defendant that is served. IT IS FURTHER ORDERED that the Notice, Consent, and Referral forms re: U.S. Magistrate Judge jurisdiction, previously docketed in this case, are VACATED. Issued by the Clerk of Court on 5/18/2022. (ntl) (Entered: 05/18/2022) (0) |
| May 18, 2022 | 12 | ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 5/20/2022 at 04:00 PM before Judge Maryellen Noreika. Apotex may, if they choose to do so, file a response to the Motion to Expedite prior to the teleconference. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 5/18/2022. (dlw) (Entered: 05/18/2022) (0) |
| May 17, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz, Attorney Deepro R. Mukerjee, and Attorney Lance A. Soderstrom - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 05/17/2022) (5) |
| May 17, 2022 | 10 | [SEALED] MOTION to Expedite Proceedings and Certification Pursuant to Local Rule 7.1.1 - filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/17/2022) (0) |
| May 17, 2022 | 9 | [SEALED] DECLARATION re 8 Opening Brief in Support,, [Declaration of Elizabeth Gutierrez] by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/17/2022) (0) |
| May 17, 2022 | 8 | [SEALED] OPENING BRIEF in Support re 7 MOTION for Preliminary Injunction and Certification Pursuant to Local Rule 7.1.1 filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC.Answering Brief/Response due date per Local Rules is 5/31/2022. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Hoeschen, Nathan) (Entered: 05/17/2022) (0) |
| May 17, 2022 | 7 | MOTION for Preliminary Injunction and Certification Pursuant to Local Rule 7.1.1 - filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (Hoeschen, Nathan) (Entered: 05/17/2022) (3) |
| May 16, 2022 | 5 | Summons Issued as to Apotex Corp. on 5/16/2022; Apotex Inc. on 5/16/2022. (Attachments: # 1 Summons Issued)(smg) (Entered: 05/16/2022) (Summons Issued) (2) |
| May 16, 2022 | 6 | SUMMONS Returned Executed by Horizon Therapeutics Ireland DAC, Horizon Medicines LLC, HZNP Medicines LLC, HZNP Finance LTD.. Apotex Corp. served on 5/16/2022, answer due 6/6/2022; Apotex Inc. served on 5/16/2022, answer due 6/6/2022. (Keller, Karen) (Entered: 05/16/2022) (4) |
| May 16, 2022 | 5 | Summons Issued as to Apotex Corp. on 5/16/2022; Apotex Inc. on 5/16/2022. (Attachments: # 1 Summons Issued)(smg) (Entered: 05/16/2022) (Main Document) (2) |
| May 13, 2022 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Horizon Therapeutics Plc for HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC filed by HZNP Finance LTD., HZNP Medicines LLC, Horizon Medicines LLC, Horizon Therapeutics Ireland DAC. (smg) (Entered: 05/16/2022) (2) |
| May 13, 2022 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number US 9,066,913 B2. (smg) (Entered: 05/16/2022) (1) |
| May 13, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) (Entered: 05/16/2022) (3) |
| May 13, 2022 | 1 | Complaint* (1) |
